Guideline to Register as a Broker of Medicinal Products
Recommendation

Tuesday, 29 September 2026 14.00 - 16.00 h
GDP-compliant Transport Processes: from Risk Assessment to Practical Implementation
All Stakeholders dealing with Medicinal Products need to be registered and have to comply with GDP requirements. According to the definition a broker is involved in independently selling or buying medicinal products on behalf of another company. As per definition a broker does not buy or sell the products, does not own the products and does not physically handle the products.
For some countries in Europe (Belgium, Spain, France, Croatia, The Netherlands, UK) the so called "Heads of Medicines Agency" provide a database to complete a Broker application. This application is the prerequisite to submit an application to the agency in the above mentioned countries. The UK for example does have a register of Brokers for Medicinal Products on their website. Currently 20 companies are listed there.
The MHRA has defined very detailed requirements which brokers have to fulfil before they are registered. The MHRA will:
- check the identities of the ‘responsible person’ and other named staff
- will perform a GDP inspection at the site of the broker
- interview the members of the staff of the broker
If the inspection was successful a GDP certificate will be issued and transferred to the EudraGMDP Database. This comprehensive control of brokers is not established in each EU country yet but other agencies might follow the example of the MHRA.
Source: MHRA Webpage for Brokers
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations


